RE:Buy the fearEarnings today, are a non issue! They are totally irrelevant to the future of the company. The expectation has always been that they will need to pay for trials to bring the future revenues. There is nothing new or surprising about it - just that these expenses are necessary to bring about the future revenues by obtaining the needed FDA aprovals. They (the shorts) are just playing on the fears of some with these menaingless numbers to scare the unknowing small retail investor who will quake at the slightest murmur of something totally inconsequential he takes as bad. It is sad for those poor retail investors but great for those of us who understand a great opportunity when they see one.